Oscar Cuzzani, MD
QLT Inc.
5
0
4
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (5)
Research Network
Collaboration Network
Research Areas & Affiliations
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Allen Ho, MD
Retina Diagnostic & Treatment Associates, LLC
Shared therapeutic areas:
Worked with same sponsors:
Andrew Strong, Ph.D
QLT Inc.
Shared therapeutic areas:
Worked with same sponsors:
Henry Hudson, MD
Retina Centers, PC
Shared therapeutic areas:
Worked with same sponsors:
Gerhard Garhöfer, MD
Department of Clinical Pharmacology, Medical University of Vienna
Shared therapeutic areas:
Alcon Investigators
Alcon Research
Shared therapeutic areas:
Kerry Stephens, O.D.
Glaukos Corporation
Shared therapeutic areas:
Leopoldo Baiza Durán, MD
Laboratorios Sophia S.A de C.V.
Shared therapeutic areas:
Steven Levy, MD
MD Stem Cells
Shared therapeutic areas:
Michael H Silverman, MD
Can-Fite BioPharma
Shared therapeutic areas:
Abayomi Ogundele, PharmD
Alcon Research
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (5)
Showing 5 of 5 trials
Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)
A Safety Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open Angle Glaucoma
Study of the Effects of Artificial Tears on the Response to the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma
A Phase 2 Study of the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma
A Study of Different Formulations of the L-PPDS in Subjects With OH or OAG
All 5 trials loaded